Our Studies

Filter by Site:

North Vancouver - Major Depressive Disorder

We are conducting a clinical research study for adults living with Major Depressive Disorder (MDD) who continue to experience symptoms despite being on antidepressant medication. The study is evaluating an investigational oral medication to see whether it may help delay relapse of depression symptoms when used together with a current antidepressant.

Site: North Shore

North Vancouver - Depression

CONTINUING TO EXPERIENCE THE EFFECTS OF DEPRESSION?

You could qualify to participate in a research study for adults who have depression.

Site: North Shore

Kelowna - Lupus

If you've been living with the skin symptoms of lupus — rashes, lesions, flares — you know how much they can impact your day-to-day life. Current treatment options don't work for everyone, and finding lasting relief can feel like a constant challenge.

That's why researchers are studying a new investigational treatment for lupus that affects the skin. This Phase 3 clinical research study is taking place at research sites around the world, including right here in Canada, and we're currently enrolling participants.

Site: Kelowna

Penticton - CVRR Outcome

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure.

Site: Penticton

Penticton - Reduction of Major Adverse Cardiovascular Events

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart attack or stroke.

Site: Penticton

North Shore - CVRR Outcome

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure.

Site: North Shore

Kelowna - CVRR Outcome

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure.

Site: Kelowna

North Vancouver - Reduction of Major Adverse Cardiovascular Events

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart attack or stroke.

Site: North Shore

Kamloops - Opioid Use Disorder

Already being treated for opioid use disorder with buprenorphine?

A Kamloops research study is exploring whether an add-on medication can offer even more support — without changing your current treatment.

Site: Kamloops

North Vancouver - Refractory Chronic Cough

The LAKE Trial is a Phase 2b clinical trial seeking to understand different doses of an investigational treatment, oral nalbuphine ER (extended release) (NAL-ER), and its potential effects on cough in patient with Refractory Chronic Cough (RCC)

Site: North Shore

Kelowna - Difficult to Control COPD with Eosinophilic Phenotype

If you've had a COPD exacerbation in the past year and are still struggling with your symptoms, you may qualify for this local research study.

Site: Kelowna

North Vancouver - Difficult to Control COPD

If you've had a COPD exacerbation in the past year and are still struggling with your symptoms, you may qualify for this local research study.

Site: North Shore

West Vancouver – Asthma

Is asthma preventing you from breathing easy? If you are diagnosed with asthma and it makes it harder for you to breathe, you could be eligible to participate in this clinical trial.

Site: North Shore

Kelowna - High Risk Asthma

Is asthma preventing you from breathing easy? If you are diagnosed with asthma and it makes it harder for you to breathe, you could be eligible to participate in this clinical trial.

Site: Kelowna

Kelowna - Uncontrolled Asthma

If you’ve had an asthma attack in the past year and are still struggling with your symptoms despite taking controlled medications, you may qualify for this research study.

Site: Kelowna

Kelowna - Severe Alopecia

This study evaluates the safety and effectiveness of deuruxolitinib in adolescents aged 12 to less than 18 years who have 50% or greater scalp hair loss.

Site: Kelowna